-
receptor 2.
After successful phase I/II trials,
human recombinant TGF-β3 (
avotermin,
planned trade name Juvista)
failed in
Phase III trials. GRCh38: Ensembl...
- ALK1 (ACVRL1) Agonists:
Activin (A, B, AB)
Avotermin BMP (10)
Cetermin GDF (2 (BMP9)) TGFβ (1, 2, 3) Antibodies: Ascrinva****ab
Kinase inhibitors: K-02288...
-
avobenzone (INN)
Avodart Avonex avoparcin (INN)
avorelin (INN)
avosentan (INN)
avotermin (INN)
avridine (INN)
Avzivi Awiqli axamozide (INN)
axatilimab (INN) Axberi...
-
molecular mechanisms.
Treatments involving molecular mechanisms including avotermin,
ribosomal s6
kinase (RSK), and
osteopontin were
investigated at the time...
- ALK1 (ACVRL1) Agonists:
Activin (A, B, AB)
Avotermin BMP (10)
Cetermin GDF (2 (BMP9)) TGFβ (1, 2, 3) Antibodies: Ascrinva****ab
Kinase inhibitors: K-02288...
- ALK1 (ACVRL1) Agonists:
Activin (A, B, AB)
Avotermin BMP (10)
Cetermin GDF (2 (BMP9)) TGFβ (1, 2, 3) Antibodies: Ascrinva****ab
Kinase inhibitors: K-02288...
- ALK1 (ACVRL1) Agonists:
Activin (A, B, AB)
Avotermin BMP (10)
Cetermin GDF (2 (BMP9)) TGFβ (1, 2, 3) Antibodies: Ascrinva****ab
Kinase inhibitors: K-02288...
- ALK1 (ACVRL1) Agonists:
Activin (A, B, AB)
Avotermin BMP (10)
Cetermin GDF (2 (BMP9)) TGFβ (1, 2, 3) Antibodies: Ascrinva****ab
Kinase inhibitors: K-02288...
- ALK1 (ACVRL1) Agonists:
Activin (A, B, AB)
Avotermin BMP (10)
Cetermin GDF (2 (BMP9)) TGFβ (1, 2, 3) Antibodies: Ascrinva****ab
Kinase inhibitors: K-02288...
- ALK1 (ACVRL1) Agonists:
Activin (A, B, AB)
Avotermin BMP (10)
Cetermin GDF (2 (BMP9)) TGFβ (1, 2, 3) Antibodies: Ascrinva****ab
Kinase inhibitors: K-02288...
